As access challenges to the site continue, Baxter has limited purchases of certain products to avoid stockpiling, manage inventory and minimize disruption to patient care.
The software turns coronary CT angiography images into 3D models that quantify and classify plaque morphology to improve predictions of heart attack and stroke risk.
PSN Labs called for a jury trial, claiming Philips is attempting to deflect attention away from its own “failures, negligence, concealment and recklessness.” ...
The settlement terms are confidential, BD said. The company disputes the lawsuit’s allegations and backs its product designs.
Philips is asking customers to immediately install a software update to address several new and previously reported safety issues, the FDA said.
After making nearly $550 million worth of acquisitions in the past few years, the medical device contract manufacturer will use proceeds from the sale to pay down debt.
More than 2,500 people work at the facility, which is Baxter’s largest manufacturing site. The company is still working to fully assess the damage.
The FDA has now approved the 3D elements, which feature a 50-degree wide-angle technology. Siemens said the angle is the widest available. The mammography system has a scan time of around five seconds ...
Called Flyrcado, the radiopharmaceutical could help improve cardiac imaging accuracy in patients with a high body mass index and women, the company said.
The Protecting Access to Medicare Act (PAMA) of 2014 tied laboratory payment rates to market data for diagnostic tests, resulting in three rounds of reimbursement cuts. ACLA and other industry groups ...
Masimo CEO and founder Joe Kiani resigned from the company after losing his board seat last week in a proxy battle with Politan Capital Management. Former Johnson & Johnson executive Michelle Brennan, ...
Recalled heart devices often lack clinical testing, researchers found in a study published last week in the Annals of Internal Medicine. Heart devices account for one-third of Class I recalls, the ...